A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury

Kidney International

Volumn 90, Issue 1, 2016, Pages 212-221

  Goldstein, Stuart L ^a   Mottes, Theresa ^a   Simpson, Kendria ^a   Barclay, Cynthia ^a   Muething, Stephen ^a   Haslam, David B ^a   Kirkendall, Eric S ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

acute kidney injury; electronic health record; nephrotoxic medications; quality improvement

Indexed keywords

CREATININE;

ACUTE KIDNEY FAILURE; ARTICLE; CREATININE BLOOD LEVEL; DECISION SUPPORT SYSTEM; DRUG EXPOSURE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK REDUCTION; TOTAL QUALITY MANAGEMENT; ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; BLOOD; CHEMICALLY INDUCED; CHILD; CLINICAL DECISION SUPPORT SYSTEM; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ELECTRONIC HEALTH RECORD; HOSPITAL; HOSPITALIZATION; INFANT; KIDNEY FUNCTION TEST; NEWBORN; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; PROGRAM EVALUATION; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ACUTE KIDNEY INJURY; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CREATININE; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ELECTRONIC HEALTH RECORDS; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY FUNCTION TESTS; PROGRAM EVALUATION; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; YOUNG ADULT;

EID: 84988373572     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.03.031     Document Type: Article

References (34)

1. 1 Hui-Stickle, S., Brewer, E.D., Goldstein, S.L., Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45 (2005), 96–101.
2. 2 Lewington, A.J., Cerda, J., Mehta, R.L., Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney Int 84 (2013), 457–467.
3. 3 Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
4. 4 Bellomo, R., Ronco, C., Kellum, J.A., et al., for the Acute Dialysis Quality Initiative Workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8 (2004), R204–R212.
5. 5 Alge, J.L., Arthur, J.M., Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol 10 (2015), 147–155.
6. 6 United States Renal Data System. USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2013, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
7. 7 Moffett, B.S., Goldstein, S.L., Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 6 (2011), 856–863.
8. 8 Goldstein, S.L., Kirkendall, E., Nguyen, H., et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 132 (2013), e756–e767.
9. 9 Olomu, A.B., Stommel, M., Holmes-Rovner, M.M., et al. Is quality improvement sustainable? Findings of the American College of Cardiology's Guidelines Applied in Practice. Int J Qual Health Care 26 (2014), 215–222.
10. 10 Douglas, S., Button, S., Casey, S.E., Implementing for sustainability: promoting use of a measurement feedback system for innovation and quality improvement. Adm Policy Ment Health 43 (2016), 286–291.
11. 11 Persaud, D.D., Enhancing learning, innovation, adaptation, and sustainability in health care organizations: the ELIAS performance management framework. Health Care Manag 33 (2014), 183–204.
12. 12 Kirkendall, E.S., Spires, W.L., Mottes, T.A., et al. Development and performance of electronic acute kidney injury triggers to identify pediatric patients at risk for nephrotoxic medication-associated harm. Appl Clin Inform 5 (2014), 313–333.
13. 13 Green, B.B., Cook, A.J., Ralston, J.D., et al. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA 299 (2008), 2857–2867.
14. 14 Bates, D.W., Cullen, D.J., Laird, N., et al., for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 274 (1995), 29–34.
15. 15 Kilcup, M., Schultz, D., Carlson, J., Wilson, B., Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings. J Am Pharm Assoc 53 (2013), 78–84.
16. 16 Bates, D.W., Leape, L.L., Cullen, D.J., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA 280 (1998), 1311–1316.
17. 17 Wilson, F.P., Shashaty, M., Testani, J., et al. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet 385 (2015), 1966–1974.
18. 18 Campbell, R., The five “rights” of clinical decision support. J AHIMA 84 (2013), 42–47 quiz 48.
19. 19 Laing, C., On the alert for outcome improvement in acute kidney injury. Lancet 385 (2015), 1924–1926.
20. 20 Institute of Medicine. To Err Is Human: Building a Safer Healthcare System. 1999, Institute of Medicine, Washington, DC.
21. 21 Nicol, N., Case study: an interdisciplinary approach to medication error reduction. Am J Health Syst Pharm 64:suppl 9 (2007), S17–S20.
22. 22 Walsh, K.E., Bundy, D.G., Landrigan, C.P., Preventing health care-associated harm in children. JAMA 311 (2014), 1731–1732.
23. 23 Leape, L.L., Berwick, D.M., Five years after To Err Is Human: what have we learned?. JAMA 293 (2005), 2384–2390.
24. 24 Landrigan, C.P., Parry, G.J., Bones, C.B., et al. Temporal trends in rates of patient harm resulting from medical care. N Engl J Med 363 (2010), 2124–2134.
25. 25 Shekelle, P.G., Pronovost, P.J., Wachter, R.M., et al. Assessing the Evidence for Context-Sensitive Effectiveness and Safety of Patient Safety Practices: Developing Criteria. 2010, Agency for Healthcare Research and Quality, Rockville, MD.
26. 26 Vachvanichsanong, P., Dissaneewate, P., Lim, A., McNeil, E., Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics 118 (2006), e786–e791.
27. 27 Akcan-Arikan, A., Zappitelli, M., Loftis, L.L., et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71 (2007), 1028–1035.
28. 28 Symons, J.M., Chua, A.N., Somers, M.J., et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2 (2007), 732–738.
29. 29 Schneider, J., Khemani, R., Grushkin, C., Bart, R., Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 38 (2010), 933–939.
30. 30 Zappitelli, M., Parikh, C.R., Akcan-Arikan, A., et al. Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 3 (2008), 948–954.
31. 31 Schetz, M., Dasta, J., Goldstein, S., Golper, T., Drug-induced acute kidney injury. Curr Opin Crit Care 11 (2005), 555–565.
32. 32 Langley, G.J., Moen, R.D., Nolan, K.M., et al. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. 2nd ed., 2009, Jossey-Bass, San Francisco, CA.
33. 33 Mohammed, M.A., Worthington, P., Woodall, W.H., Plotting basic control charts: tutorial notes for healthcare practitioners. Qual Saf Health Care 17 (2008), 137–145.
34. 34 Muething, S.E., Goudie, A., Schoettker, P.J., et al. Quality improvement initiative to reduce serious safety events and improve patient safety culture. Pediatrics 130 (2012), e423–e431.